Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine

Takahiro Kishikawa, Motoyuki Otsuka, Poh Seng Tan, Motoko Ohno, Xiaochen Sun, Takeshi Yoshikawa, Chikako Shibata, Akemi Takata, Kentaro Kojima, Kenji Takehana, Maki Ohishi, Sana Ota, Tomoyuki Noyama, Yuji Kondo, Masaya Sato, Tomoyoshi Soga, Yujin Hoshida, Kazuhiko Koike

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Reduced expression of microRNA122 (miR122), a liver-specific microRNA, is frequent in hepatocellular carcinoma (HCC). However, its biological significances remain poorly understood. Because deregulated amino acid levels in cancers can affect their biological behavior, we determined the amino acid levels in miR122- silenced mouse liver tissues, in which intracellular arginine levels were significantly increased. The increased intracellular arginine levels were through upregulation of the solute carrier family 7 (SLC7A1), a transporter of arginine and a direct target of miR122. Arginine is the substrate for nitric oxide (NO) synthetase, and intracellular NO levels were increased in miR122-silenced HCC cells, with increased resistance to sorafenib, a multikinase inhibitor. Conversely, maintenance of the miR122-silenced HCC cells in arginine-depleted culture media, as well as overexpression of miR122 in miR122-low-expressing HCC cells, reversed these effects and rendered the cells more sensitive to sorafenib. Using a reporter knock-in construct, chemical compounds were screened, and Wee1 kinase inhibitor was identified as upregulators of miR122 transcription, which increased the sensitivity of the cells to sorafenib. These results provide an insight into sorafenib resistance in miR122-low HCC, and suggest that arginine depletion or a combination of sorafenib with the identified compound may provide promising approaches to managing this HCC subset.

Original languageEnglish
Pages (from-to)8339-8352
Number of pages14
JournalOncotarget
Volume6
Issue number10
DOIs
Publication statusPublished - 2015 Jan 1
Externally publishedYes

Keywords

  • Arginine
  • HCC
  • MiR122
  • Nitric oxide
  • SLC7A1

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine'. Together they form a unique fingerprint.

  • Cite this

    Kishikawa, T., Otsuka, M., Tan, P. S., Ohno, M., Sun, X., Yoshikawa, T., Shibata, C., Takata, A., Kojima, K., Takehana, K., Ohishi, M., Ota, S., Noyama, T., Kondo, Y., Sato, M., Soga, T., Hoshida, Y., & Koike, K. (2015). Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget, 6(10), 8339-8352. https://doi.org/10.18632/oncotarget.3234